|
MRPL55 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.12132525487141E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.84680000000692E-05 |
| Normal-vs-Stage2 |
1.587240E-04 |
| Normal-vs-Stage3 |
4.81337192326237E-12 |
| Normal-vs-Stage4 |
3.01419999959585E-07 |
| Stage1-vs-Stage2 |
1.417040E-01 |
| Stage1-vs-Stage3 |
4.984200E-02 |
| Stage1-vs-Stage4 |
4.255600E-02 |
| Stage2-vs-Stage3 |
6.895200E-01 |
| Stage2-vs-Stage4 |
9.383400E-01 |
| Stage3-vs-Stage4 |
5.434200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.77144973637178E-12 |
| Normal-vs-AfricanAmerican |
1.774130E-04 |
| Normal-vs-Asian |
3.071600E-01 |
| Caucasian-vs-AfricanAmerican |
1.365200E-01 |
| Caucasian-vs-Asian |
8.316000E-01 |
| AfricanAmerican-vs-Asian |
4.618400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.1437994995589E-10 |
| Normal-vs-Female |
1.2080999534092E-09 |
| Male-vs-Female |
6.817800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.502300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.75359957058186E-10 |
| Normal-vs-Age(61-80Yrs) |
1.26630000041317E-07 |
| Normal-vs-Age(81-100Yrs) |
3.228200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.389800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.519000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.978300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.022200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.038300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.590800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.997800E-02 |
| Normal-vs-Grade 2 |
1.180980E-04 |
| Normal-vs-Grade 3 |
1.62625468647093E-12 |
| Normal-vs-Grade 4 |
6.89119999952581E-07 |
| Grade 1-vs-Grade 2 |
4.088000E-01 |
| Grade 1-vs-Grade 3 |
4.673900E-02 |
| Grade 1-vs-Grade 4 |
1.514110E-02 |
| Grade 2-vs-Grade 3 |
1.586790E-01 |
| Grade 2-vs-Grade 4 |
4.946100E-02 |
| Grade 3-vs-Grade 4 |
2.423200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.11950000381E-08 |
| Normal-vs-ccB subtype |
1.41160000022289E-07 |
| ccA subtype-vs-ccB subtype |
9.960000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.01269999994458E-06 |
| Normal-vs-N1 |
1.121690E-02 |
| N0-vs-N1 |
5.129000E-01 |
|
|
